Back

Impact of real-time 3D echocardiography on device time, success of the procedure and outcome in mitraclip implantation

5 December 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - 3D Echocardiography 3D Echocardiography EACVI Premium Access EuroEcho-Imaging 2018

About the speaker

Photo
Professor Rodolfo Citro

University of Molise, Campobasso (Italy)

10 More presentations in this session

Presentation thumbnail
Non inferior results in direct mitral valve planimetry with three dimensional (3D) echocardiography compared to multiplanar reconstruction (MPR)
Assistant Professor N. Khezerlou (Tabriz, IR)
Abstract Slides
Presentation thumbnail
3D assessment of the tricuspid annulus in sinus rhythm and atrial fibrillation: does measurement methodology matter?
Doctor V. Volpato (Milan, IT)
Abstract
Presentation thumbnail
Left ventricular torsion as marker of disease severity in patients with non-ischemic dilated cardiomyopathy based on three-dimensional echocardiography
Doctor M. Rady (Chemnitz, DE)
Abstract Slides
Presentation thumbnail
Decreased right ventricular-arterial coupling in newly diagnose stage I-II never treated hypertensive patients
Professor D. Galzerano (Riyadh, SA)
Abstract
Presentation thumbnail
Prognostic value of echo contrast enhanced 3D dobutamine stress echocardiography.
Professor B. Shivalkar (Brussels, BE)
Abstract

Access the full session

Session thumbnail
Poster session 1 - 3D Echocardiography

The Event

Event poster

EuroEcho-Imaging 2018

5 December - 8 December 2018
You may be interested in
thumbnail
Congress Presentation
Future of 3D echocardiography in congenital heart disease: role of education, training, and technical development to meet growing requirements of ACHD clinical service
thumbnail
Congress Presentation
Added value of 3D echocardiography for assessment of shunt lesions in adult patients with congenital heart disease
thumbnail
Congress Session
Three-dimensional echocardiography in the assessment of adult patients with congenital heart disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources